Information for Industry

Guidance on the regulatory processes for suppliers in New Zealand of medicines and medical devices.

Approval Process

Date	Type	Title
23/09/2020	Consultation	Outcome of the consultation on the proposed warning statements for substances (eg, allergens) in medicines that may cause undesirable reactions
16/09/2020	Alert Communication	Medsafe is issuing a warning that Elevacity Elevate Smart Coffee (Version 3) should not be consumed - statement under section 98 of the Medicines Act 1981
15/09/2020	Media Release	Medsafe takes action to prevent the supply of illegally marketed medicine linked to liver harm
11/09/2020	Committees	Medicines Classification Committee - Dates and Deadlines
11/09/2020	Committees	Agenda for the 65th Medicines Classification Committee meeting
11/09/2020	Media Release	Medsafe has completed its review of Objections from the 64th Medicines Classification Committee to reclassify pholcodine
3/09/2020	Publications	Prescriber Update 41(3) - September 2020
18/08/2020	Committees	Medicines Classification Committee - Dates and Deadlines
18/08/2020	Committees	Minutes of the 64th meeting of the Medicines Classification Committee - 9 July 2020
17/08/2020	Notices	Part 8: Pharmacovigilance Edition 2.2 and Summary of Changes made
11/08/2020	Committees	Medicines Classification Committee - Dates and Deadlines
31/07/2020	Monitoring Communication	Rocuronium bromide solution for injection 10mg/mL, Hameln, and reports of lack of efficacy
29/07/2020	Committees	Medicines Classification Committee - Reclassification of Codeine

If you have a query that is not answered by the information in this section please contact us at askmedsafe@health.govt.nz